GlassScriptPhysician profile
John W Womack
NPI 1366579666
$95,984.64
in general payments reported to CMS, 2019-2025
14 companies · $19K in 2025
The $19K reported for 2025 was more than what 84% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,032 · 2020: $573 · 2021: $1,852 · 2022: $20K · 2023: $30K · 2024: $21K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $30K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Travel and Lodging: $17K · Food and Beverage: $4,244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $30,082.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,950.00 |
| Travel and Lodging | $17,458.76 |
| Food and Beverage | $4,243.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $42,658.59 | 2019-2025 | Prostep, Prophecy, Prostep Mica |
| Smith+Nephew, INC. | $34,509.67 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium, Healicoil |
| Arthrex, INC. | $10,381.75 | 2019-2025 | |
| Peerless Surgical INC. | $7,249.83 | 2019-2025 | |
| Wright Medical Technology, INC. | $445.39 | 2019-2020 | |
| Medtronic, INC. | $168.87 | 2024 | Vanta Adaptivestim |
| Treace Medical Concepts, INC. | $152.94 | 2022-2025 | |
| Sanara Medtech INC. | $145.35 | 2024 | Celleraterx |
| Medical Device Business Services, INC. | $121.82 | 2019 | |
| Abbvie INC. | $60.63 | 2021-2022 | |
| Trice Medical, INC. | $52.96 | 2024 | |
| Horizon Therapeutics Plc | $13.91 | 2019 | |
| Zimmer Biomet Holdings, INC. | $11.86 | 2019 | |
| Bioventus LLC | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Womack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.